Cellular abnormalities can influence how cancer responds to treatment. For example, tumors with certain genetic mutations may be resistant to standard therapies but sensitive to targeted treatments. Personalized medicine, which tailors treatment based on specific genetic and molecular profiles, is increasingly important in cancer care.
